Close Menu

PathGroup

Some of the firms will receive money to speed up test development, while others will use the funds to expand their testing and manufacturing capacity.

The firms will partner on studies needed to support and secure US regulatory approval for the Elio tissue complete assay.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.